|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
1 | AN ACT concerning health.
| ||||||||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||||||||
4 | Section 5. The Mental Health and Developmental | ||||||||||||||||||||||||||||||
5 | Disabilities Administrative Act is amended by adding Section | ||||||||||||||||||||||||||||||
6 | 10.5 as follows: | ||||||||||||||||||||||||||||||
7 | (20 ILCS 1705/10.5 new) | ||||||||||||||||||||||||||||||
8 | Sec. 10.5. Prevention and control of Multidrug-Resistant | ||||||||||||||||||||||||||||||
9 | Organisms. The Department, in consultation with the Department | ||||||||||||||||||||||||||||||
10 | of Public Health, shall adopt rules requiring facilities | ||||||||||||||||||||||||||||||
11 | described in Section 4 of this Act to implement comprehensive | ||||||||||||||||||||||||||||||
12 | interventions to prevent and control multidrug-resistant | ||||||||||||||||||||||||||||||
13 | organisms (MDROs), including methicillin-resistant | ||||||||||||||||||||||||||||||
14 | Staphylococcus aureus (MRSA), vancomycin-resistant | ||||||||||||||||||||||||||||||
15 | enterococcci (VRE), and certain gram-negative bacilli (GNB), | ||||||||||||||||||||||||||||||
16 | pursuant to prevention and control interventions recommended | ||||||||||||||||||||||||||||||
17 | by the U.S. Centers for Disease Control and Prevention (2006). | ||||||||||||||||||||||||||||||
18 | The Department shall also require facilities to submit reports | ||||||||||||||||||||||||||||||
19 | to the Department that contain substantially the same | ||||||||||||||||||||||||||||||
20 | information contained in the related infection reports | ||||||||||||||||||||||||||||||
21 | required to be submitted by hospitals to the Department of | ||||||||||||||||||||||||||||||
22 | Public Health under Section 25 of the Hospital Report Card Act. | ||||||||||||||||||||||||||||||
23 | The Department shall provide that information to the Department |
| |||||||
| |||||||
1 | of Public Health upon the Department of Public Health's | ||||||
2 | request. | ||||||
3 | In addition to requiring implementation of the | ||||||
4 | interventions recommended by the U.S. Centers for Disease | ||||||
5 | Control and Prevention, the Department shall require | ||||||
6 | facilities to establish and implement procedures for routinely | ||||||
7 | testing all patients for methicillin-resistant Staphylococcus | ||||||
8 | aureus (MRSA) (i) upon admission to the facility and (ii) on a | ||||||
9 | repeated basis as necessary to prevent the infection of other | ||||||
10 | facility patients or facility personnel or visitors. | ||||||
11 | Section 10. The Department of Public Health Powers and | ||||||
12 | Duties Law of the
Civil Administrative Code of Illinois is | ||||||
13 | amended by adding Section 2310-312 as follows: | ||||||
14 | (20 ILCS 2310/2310-312 new) | ||||||
15 | Sec. 2310-312. Multidrug-Resistant Organisms. The | ||||||
16 | Department shall perform the following functions in relation to | ||||||
17 | the prevention and control of Multidrug-Resistant Organisms | ||||||
18 | (MDROs), including methicillin-resistant Staphylococcus aureus | ||||||
19 | (MRSA), vancomycin-resistant (VRE) and certain gram-negative | ||||||
20 | bacilli (GNB), as these terms are referenced by the United | ||||||
21 | States Centers for Disease Control and Prevention: | ||||||
22 | (1) The Department shall adopt administrative rules | ||||||
23 | for all health care facilities subject to licensure, | ||||||
24 | certification, registration, or other regulation by the |
| |||||||
| |||||||
1 | Department requiring compliance with the 2006 | ||||||
2 | recommendations of the U.S. Centers for Disease Control and | ||||||
3 | Prevention for the prevention and control of | ||||||
4 | Multidrug-Resistant Organisms (MDROs). | ||||||
5 | (2) The Department shall conduct a public information | ||||||
6 | campaign for health care providers not subject to | ||||||
7 | regulation by the Department, including physicians, health | ||||||
8 | facilities, public health departments, other public and | ||||||
9 | private health care providers, laboratories, and the | ||||||
10 | general public, on Multidrug Resistant Organisms (MDROs) | ||||||
11 | to reduce the incidence of infection. This program shall | ||||||
12 | include, but need not be limited to, the establishment of a | ||||||
13 | statewide information clearinghouse that will provide | ||||||
14 | periodic reports and releases to public officials, health | ||||||
15 | professionals, and the general public regarding new | ||||||
16 | developments or procedures concerning prevention and | ||||||
17 | treatment of MDROs. | ||||||
18 | (3) The Department shall create and administer a | ||||||
19 | training program for health care providers who have a need | ||||||
20 | for understanding matters relating to MDROs. The training | ||||||
21 | shall include information on the cause and effects of MDROs | ||||||
22 | and the means of preventing and controlling transmission. | ||||||
23 | The training may be made available to public employees and | ||||||
24 | the employees of private agencies. The Department may | ||||||
25 | charge fees to cover the costs of the training. | ||||||
26 | (4) The Department shall recommend and approve tests or |
| |||||||
| |||||||
1 | testing procedures used in determining, preventing, and | ||||||
2 | controlling MDRO infection. | ||||||
3 | Section 15. The University of Illinois Hospital Act is | ||||||
4 | amended by adding Section 7 as follows: | ||||||
5 | (110 ILCS 330/7 new) | ||||||
6 | Sec. 7. Prevention and control of Multidrug-Resistant | ||||||
7 | Organisms. The University, in consultation with the Department | ||||||
8 | of Public Health, shall adopt rules requiring the University of | ||||||
9 | Illinois hospital to implement comprehensive interventions to | ||||||
10 | prevent and control multidrug-resistant organisms (MDROs), | ||||||
11 | including methicillin-resistant Staphylococcus aureus (MRSA), | ||||||
12 | vancomycin-resistant enterococcci (VRE), and certain | ||||||
13 | gram-negative bacilli (GNB), pursuant to prevention and | ||||||
14 | control interventions recommended by the U.S. Centers for | ||||||
15 | Disease Control and Prevention (2006). The University shall | ||||||
16 | also require the Hospital to submit reports to the University | ||||||
17 | that contain substantially the same information contained in | ||||||
18 | the related infection reports required to be submitted by | ||||||
19 | hospitals to the Department of Public Health under Section 25 | ||||||
20 | of the Hospital Report Card Act. The University shall provide | ||||||
21 | that information to the Department of Public Health upon the | ||||||
22 | Department's request. | ||||||
23 | In addition to requiring implementation of the | ||||||
24 | interventions recommended by the U.S. Centers for Disease |
| |||||||
| |||||||
1 | Control and Prevention, the University shall require the | ||||||
2 | University of Illinois Hospital to establish and implement | ||||||
3 | procedures for routinely testing all patients for | ||||||
4 | methicillin-resistant Staphylococcus aureus (MRSA) (i) upon | ||||||
5 | admission to the hospital and (ii) on a repeated basis as | ||||||
6 | necessary to prevent the infection of other hospital patients | ||||||
7 | or hospital personnel or visitors. | ||||||
8 | Section 20. The Hospital Licensing Act is amended by adding | ||||||
9 | Section 6.23 as follows: | ||||||
10 | (210 ILCS 85/6.23 new) | ||||||
11 | Sec. 6.23. Prevention and control of Multidrug-Resistant | ||||||
12 | Organisms. The Department shall adopt rules requiring | ||||||
13 | hospitals licensed under this Act to implement comprehensive | ||||||
14 | interventions to prevent and control multidrug-resistant | ||||||
15 | organisms (MDROs), including methicillin-resistant | ||||||
16 | Staphylococcus aureus (MRSA), vancomycin-resistant | ||||||
17 | enterococcci (VRE), and certain gram-negative bacilli (GNB), | ||||||
18 | pursuant to prevention and control interventions recommended | ||||||
19 | by the U.S. Centers for Disease Control and Prevention (2006). | ||||||
20 | The Department shall also require hospitals to submit related | ||||||
21 | infection reports under Section 25 of the Hospital Report Card | ||||||
22 | Act. | ||||||
23 | In addition to requiring implementation of the | ||||||
24 | interventions recommended by the U.S. Centers for Disease |
| |||||||
| |||||||
1 | Control and Prevention, the Department shall require hospitals | ||||||
2 | to establish and implement procedures for routinely testing all | ||||||
3 | patients for methicillin-resistant Staphylococcus aureus | ||||||
4 | (MRSA) (i) upon admission to the hospital and (ii) on a | ||||||
5 | repeated basis as necessary to prevent the infection of other | ||||||
6 | hospital patients or hospital personnel or visitors.
| ||||||
7 | Section 99. Effective date. This Act takes effect upon | ||||||
8 | becoming law.
|